Medscape1h
FDA Approves Dupilumab as Add-On for COPD
The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic ...
FDA issues recalls on at least 16 food and drug items in September. Here's a list
The FDA has removed the following items from store shelves this September, including pet food, baby powder and Lactaid.
US FDA approves GE HealthCare's diagnostic drug for heart disease
The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...
FDA Recalls Gluten-Free Cake and Gives Risk Classification
The "mini raspberry lemon coffee cake" was recalled due to potentially containing undeclared wheat flour and walnuts.
FDA approves 1st new drug for schizophrenia in more than 30 years
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...
FDA Approves the First New Schizophrenia Drug in Decades
Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...
Column: A federal appeals court hands the FDA a stupendous win in its battle against stem cell clinics
The FDA claimed these clinics were plying patients with an illegal drug derived from their stem cells. A federal court agrees ...
FDA approves new schizophrenia drug
The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia,  the FDA announced Thursday.
US FDA lifts clinical hold on Biomea's diabetes trials after safety review
The U.S. Food and Drug Administration lifted a clinical hold on Biomea Fusion's ongoing studies of its experimental drug for ...
MedPage Today3d
COVID Preventive Drug Should Work Against Circulating Variants, FDA Now Says
The FDA has determined that the monoclonal antibody pemivibart (Pemgarda) is likely to be effective against currently ...
STAT56m
Five things FDA ad comm members want
Five ways reforming the ad comms process can help the FDA to continue making the best evidence-based decisions and ensure the ...
Bristol-Myers Stock Gains on FDA Approval for New Schizophrenia Drug
Shares in Bristol-Myers Squibb (BMY) surged Friday, after the Food and Drug Administration approved the drugmaker's novel ...